Skip to Main Content
Volastra
Menu Button
Our Platform
OUR PIPELINE
Our Team
Join Us
Partnering
News & Views
News
Category:
In the News
On heels of landmark approval, Bristol Myers Squibb embarks on billion-dollar oncology deal with metastatic cancer startup
March 21, 2022
Endpoints News
Bristol Myers lands $1.1B biobucks oncology pact with Volastra, a biotech with phones ‘ringing off the hook’
March 21, 2022
Fierce Biotech
Researchers see a ‘tractable approach’ to taming cancer metastasis
April 8, 2021
STAT
Volastra, Microsoft team up to battle cancer
April 7, 2021
Wall Street Journal
With fresh investor cash in hand, Volastra partners with Microsoft to develop metastatic cancer biomarker platform
April 6, 2021
Endpoints
Load More
